Atrys Health, S.A. (ATRY.MC)

6.34 €

-0.30 (-4.52%)
Rating:
Recommendation:
-
Symbol ATRY.MC
Price 6.34 €
Beta 0.327
Volume Avg. 0.01M
Market Cap 466.863M
Shares () -
52 Week Range 0.0-10.85
1y Target Est -
DCF Unlevered ATRY.MC DCF ->
DCF Levered ATRY.MC LDCF ->
ROE -
ROA -
Operating Margin -
Debt / Equity 102.57% Buy
P/E -13.78 Strong Sell
P/B 0.15 Neutral
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades


Healthcare
Biotechnology
Madrid Stock Exchange

Atrys Health, S.A., a biomedical company, provides diagnostic services and medical treatments. The company offers diagnostic services in the fields of pathology, hematology, molecular pathology, and genetics; and diagnostic second opinion, test directory, and clinical trials and R&D services. It uses telemedicine to provide its services in the medical specialties of radiology, cardiology, ophthalmology, and dermatology. The company also provides radiotherapy; and develops therapeutic modalities and diagnostic tools. The company was formerly known as Althia Health, S.L. and changed its name to Atrys Health, S.A. in May 2016. Atrys Health, S.A. was incorporated in 2007 and is headquartered in Madrid, Spain.